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Purpose.TodeterminewhethertransplantationofSchwanncells(SCs)overexpressingdiﬀerentisoformsofﬁbroblastgrowthfactor
2 (FGF-2) combined with manual stimulation (MS) of vibrissal muscles improves recovery after facial nerve transection in adult
rat. Procedures. Transected facial nerves were entubulated with collagen alone or collagen plus na¨ ıve SCs or transfected SCs. Half
of the rats received daily MS. Collateral branching was quantiﬁed from motoneuron counts after retrograde labeling from 3 facial
nerve branches. Quality assessment of endplate reinnervation was combined with video-based vibrissal function analysis. Results.
There was no diﬀerence in the extent of collateral axonal branching. The proportion of polyinnervated motor endplates for either
na¨ ıve SCs or FGF-2 over-expressing SCs was identical. Postoperative MS also failed to improve recovery. Conclusions.N e i t h e r
FGF-2 isoform changed the extent of collateral branching or polyinnervation of motor endplates; furthermore, this motoneuron
response could not be overridden by MS.
Copyright © 2009 Kirsten Haastert et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
It has been well established that artiﬁcial nerve grafts
ﬁlled with na¨ ıve Schwann cells (SCs) from neonatal [1, 2]
and adult rats [3–5] stimulate peripheral nerve ﬁber
regeneration. The growth-promoting eﬀect is thought
to occur as a result of the SCs ability to provide basal
membrane components and to secrete a range of trophic
factors including ﬁbroblast growth factor-2 (FGF-2) [6, 7].
In the central nervous system (CNS), FGF-2 could cause
demyelination [8] and it is also known to protect diﬀerent
neuronal cell types from damage-induced death [9]. One
example is the developing and adult nigrostriatal system,
where applied exogenous FGF-2 promotes survival and
neurite outgrowth of dopaminergic neurons and protects
them from neurotoxin-induced death in vitro and in vivo
[10].
In the peripheral nervous system (PNS) especially FGF-2
appears to be a particularly potent promoter of regeneration
[11]. For example, entrapment of FGF-2 in synthetic nerve
guidance channels enhances the growth of myelinated and
unmyelinated axons across long gaps [12, 13], which are
a major challenge in peripheral nerve repair. Furthermore,
transgenic mice overexpressing FGF-2 have considerably2 Journal of Biomedicine and Biotechnology
Figure 1:Surgical procedure: entubulationofthefacial nervetrunk
after transection (adapted from [21]).
faster regeneration of peripheral axons and remyelination
compared to wildtypes [14]. As another example, genetically
modiﬁed SC overexpressing the 21- and 23-kD-FGF-2
isoforms(FGF-221/23kD)haveturnedouttobeausefultoolto
bridge long gaps (15mm) after sciatic nerve injury, a mixed
peripheral nerve [15].
Our group has addressed the problems inherent in PNS
regeneration using transection and suture of the infratempo-
ral portion of the facial nerve in rats [16]. One of our major
recent ﬁndings was that brief manual stimulation (MS; 5
minutesperday,5daysperweekfor2months)ofthewhisker
pad muscles can over-ride the functional deﬁcit after facial
nerveinjuryandend-to-endanastomosisandrestorenormal
whisking. Manual stimulation neither reduces branching at
theinjurysitenor,consequently,restoresmyotopicorganiza-
tioninthefacialnucleus.Rather,manualstimulationappears
to aﬀect the periphery by shifting the balance from abnormal
polyinnervation of the motor end-plates to the more normal
monoinnervated state [17].
Given the eﬀectiveness of manual stimulation in over-
riding the detrimental eﬀects of collateral branching and
its resultant polyinnervation of motor endplates after facial
nerve injury, we asked whether a combinatorial therapy
would also improve function. Since the diﬀerent FGF-2
isoforms (FGF-218kD and FGF-221/23kD)p r o m o t ee n c o u r a g -
ing eﬀects after injury in other peripheral nerves, namely,
the sciatic [15, 18], we ﬁrst asked here whether these
isoforms would also beneﬁt the outcome after facial nerve
injury.
Then we asked whether FGF-2 treatment combined
with manual stimulation might also inﬂuence an outcome.
We, therefore, compared the extent of sprouting, degree of
polyinnervation, and whisking function after facial nerve
transection followed by entubulation of both ends into a
silicone tube ﬁlled thereafter either with collagen type I [19],
or with collagen plus SCs genetically modiﬁed to overexpress
the low- (18-kD) or high- (21/23-kD) molecular-weight
isoformsofFGF-2[20]inanimalseitherreceivingMSornot.
2.MaterialsandMethods
2.1. Animal Groups and Overview of Experiments. 144
female adult (175–200g) rats (Sprague-Dawley, Harlan-
Winkelmann, Borchen, Germany) divided into one intact
and 8 experimental groups were used. Animals were kept on
standard laboratory food (Ssniﬀ, D-59494 Soest, Germany)
and tap water ad libitum with an artiﬁcial light-dark cycle
of 12 hours light on, 12 hours oﬀ.A l le x p e r i m e n t sw e r e
conducted in accordance with the “German Law for Animals
Protection” and were approved by the local animal care
committee(BezirksregierungK¨ oln,Az.23.203.2-K35,13/95).
Normal, intact rats were used while all animals in the 8
experimental groups had their right facial nerves transected
and were treated as follows (n = 16 in each):
(i) Group 1: intact rats,
(ii) Group 2: entubulation into a conduit containing
collagen type I,
(iii) Group 3: entubulation into a conduit containing
(na¨ ıve) nonmanipulated neonatal Schwann cells
(SCs);
(iv) Group 4: entubulation into a conduit containing SCs
overexpressing FGF-218kD (SC-FGF-218kD);
(v) Group 5: entubulation into a conduit containing SCs
overexpressing FGF221/23kD (SC-FGF221/23kD);
( v i )G r o u p6 :a sf o rg r o u p2+m a n u a ls t i m u l a t i o n( M S )
of the right whisker pad muscles
(vii) Group 7: as for group 3 + manual stimulation (MS)
(viii) Group 8: as for group 4 + MS
(ix) Group 9: as for group 5 + MS
At2monthspostoperativelywequantiﬁed(i)vibrissalmotor
performance, (ii) the degree of axonal branching, and (iii)
the pattern of motor endplate reinnervation. Data from each
experimental group (groups 2–9) were compared to those
from intact rats (group 1). Vibrissal motor performance
was analysed in all rats using video-based motion analysis
(Table 1) whereuponhalf (n = 8 per group) of the animals in
all groups were used to quantify collateral axonal branching
using triple retrograde neuronal labeling (Table 2). The
remaining rats (n = 8 per group) were used to determine the
proportion of mono- and polyinnervated motor endplates
(Table 3) in the ipsilateral levator labii superioris muscle
using immunocytochemistry.
2.2. Surgery. All surgery was performed unilateraly under
an operating microscope and with surgical anesthesia
(ketamin/xylazin (100mg Ketanest and 5mg Rompun per
kg body weight; IP) as already described [21]. The main
trunk of the facial nerve was transected and the two stumps
inserted into a silicone precision tube with an inner diameter
of 1.47mm and an outer diameter of 1.96mm (Aromando
Medizintechnik, Cat. Nr. 602-235, D¨ usseldorf). The inters-
tump distance measured 5mm (Figure 1). The empty space
between the proximal and distal nerve stumps with a volumeJournal of Biomedicine and Biotechnology 3
Table 1: Estimation of vibrissae function recovery. Vibrissae performance in unoperated rats (Group 1: Intact), in rats after transection of
the right facial nerve followed by entubulation with collagen only (Group 2: Collagen), with collagen plus neonatal Schwann cells (Group
3: Collagen + naive SCs), or with collagen plus genetically modiﬁed SCs (Groups 4 and 5). In groups 6–9 entubulations were followed by
manual mechanical stimulation (MS) of the vibrissal muscles.
Group of animals Frequency
(in Hz)
Angle at maximal
protraction (in
degrees)
Amplitude
(in degrees)
Angular velocity
during protraction
(in degrees/sec)
(1) Intact SD rats 6.0 ±0.96 0 ±15 47 ±18 635 ±395
(2) Collagen only 5.4 ±1.29 3 ±16∗ 15 ± 9∗ 213 ±44∗
(3) Collagen + neonatal, naive SCs 6.0 ±0.79 0 ±8∗ 16 ± 9∗ 140 ±90∗
(4) Collagen + SC-FGF-218kD 6.0 ±0.59 1 ±8∗ 19 ± 4∗ 238 ±164∗
(5) Collagen + SC-FGF-221/23kD 6.0 ±0.69 6 ±10∗ 11 ± 4∗ 109 ±62∗
(6) Collagen only + MS 5.8 ±1.69 3 ±19∗ 20 ± 8∗ 295 ±78∗
(7) Collagen + neonatal, naive SCs + MS 7.4 ±1.39 7 ±18∗ 16 ± 9∗ 238 ±54∗
(8) Collagen + SC-FGF-218kD +M S 6.4 ±0.99 6 ±12∗ 15 ± 8∗ 240 ±96∗
(9) Collagen + SC-FGF-221/23kD +M S 6.2 ±0.69 6 ±16∗ 19 ± 7∗ 307 ±98∗
∗Signiﬁcant diﬀerences of group mean values (ANOVA and post-hoc Tukey’s test, P<. 05) from intact rats.
Table 2: Projection patterns of facial motoneurons. Number of motoneurons with axons in the zygomatic, buccal, or marginal mandibular
branches of the facial nerve of intact rats (Group 1: Intact), in rats after transection of the right facial nerve followed by entubulation with
collagen only (Group 2: Collagen), with collagen plus naive SC’s (Group 3: Collagen+SC’s), or with collagen plus genetically modiﬁed SC’s
(groups 4 and 5). In groups 6–9 entubulations were followed by manual mechanical stimulation (MS) of the vibrissal muscles.
Group of animals
Neurons
projecting
only into
the
zygomatic
nerve
(Dil-only)
Neurons
projecting into
the zygomatic
and buccal
nerves (Dil+FG)
Neurons
projecting into
the zygomatic
and marginal
mandibular
nerves
(Dil+FB)
All Dil labeled
neurons
projecting into
the zygomatic
nerve (Dil,
DiI+FG,
DiI+FB)
Neurons
projecting
only into the
buccal nerve
(FG-only)
Neurons
projecting
only into the
marginal
mandibular
nerve
(FB-only)
Total number of
neurons projecting
into zygomatic
buccal and marginal
mandibular nerves
(Dil-only, FG-only,
FB-only)
(1) Intact SD rats 291 ± 35 — — 291± 35 1406 ± 214 349 ± 78 2046 ± 327
100% 0% 0% 100%
(2) Collagen only 323 ± 67 202 ± 58∗ 161 ± 60∗ 696 ±192∗ 2387 ± 256∗ 1976 ± 243∗ 5059 ± 691∗
46% 29% 25% 100%
(3) Collagen +
na¨ ıve Schwann
cells (SC’s)
372 ± 88 174 ± 66∗ 138 ± 73∗ 684 ± 215∗ 2040 ± 443∗ 1754 ± 509∗ 4478 ± 1167∗
54% 25% 21% 100%
(4) Collagen +
SC-FGF-218KD
234 ± 68 130 ± 54∗ 83 ± 41∗ 447±162∗ 2062 ± 296∗ 1883 ± 184∗ 4392 ± 642∗
52% 29% 19% 100%
(5) Collagen +
SC-FGF-221/23KD
269 ± 115 151 ± 70∗ 110 ± 52∗ 532 ± 232∗ 2304 ± 363∗ 1918 ± 334∗ 4754 ± 929∗
50% 28% 22% 100%
(6) Collagen only+
MS
322 ± 68 184 ± 86∗ 128 ± 43∗ 634 ± 197∗ 2243 ± 423∗ 1784 ± 523∗ 4670 ± 1143∗
51% 29% 20% 100%
(7) Collagen +
na¨ ı v eS C ’ s+M S
321 ± 87 186 ± 36∗ 168 ± 78∗ 675 ± 201∗ 2190 ± 543∗ 1752 ± 309∗ 4617 ± 1053∗
48% 28% 24% 100%
(8) Collagen +
SC-FGF-218KD +
MS
252 ± 91 330 ± 93∗ 177 ± 45∗ 759 ± 229∗ 2215 ± 204∗ 1965 ± 492∗ 4939 ± 925∗
33% 43% 24% 100%
(9) Collagen +
SC-FGF-221/23KD +
MS
303 ± 69 333 ± 96∗ 195 ± 48∗ 831 ± 213∗ 2280 ± 306∗ 1899 ± 723∗ 5010 ± 1242∗
36% 40% 24% 100%
∗Signiﬁcant diﬀerences of group mean values (ANOVA and post-hoc Tukey’s test, P<. 05) from intact rats.4 Journal of Biomedicine and Biotechnology
of approximately 8mm3 (5mm × 1,47/22 mm ×π)w a s
ﬁlled carefully with the following.
(i) 10μLc o l l a g e nt y p eIf o rg r o u p s2a n d6 ;
(ii) 10μL taken from a gel consisting of 66μL collagen
type I (Serva, Cat. No. 47254) plus 33μLo fa
suspension containing na¨ ıve nonmanipulated SC for
groups 3 and 7;
(iii) 10μL taken from a gel consisting of 66μL colla-
gen type I plus 33μL of a suspension containing
genetically modiﬁed SCs overexpressing FGF-218kD
for groups 4 and 8;
(iv) 10μL taken from a gel consisting of 66μL collagen
t y p eIp l u s3 3μL of a suspension containing genet-
ically modiﬁed SCs overexpressing FGF-221/23kD for
groups 5 and 9.
2.3. Collagen and Schwann Cell Preparation. The collagen
gel was obtained from a stock solution (100μg/mL, Serva,
Heidelberg,Germany,Cat.No.47254)whichwasmixedwith
×10 phosphate buﬀered saline (PBS) and 0.1M NaOH till
the pH reached 7.4. Thereafter, 106μL of this pure collagen
g e lw e r em i x e dw i t h5 4 μL collagen (ratio 2 : 1) which
contained a suspension of Schwann cells so that a total of
160μL gel (collagen plus SC) was obtained. This volume was
then divided in 16 tubes (for 16 rats) each containing 10μL,
that is, the portion for each animal. To polymerize in a 3-
dimensional gel, the collagen/SC mixture was left at 37◦C
for 2 hours [22, 23]. Each animal received approximately
0.2 × 106 cells.
Primary physiological Schwann cells were prepared as
described earlier [24]. In brief, sciatic nerves were dis-
sected from neonatal Sprague-Dawley rats. After enzymatic
dissociation and primary seeding, most of contaminating
ﬁbroblasts were erased by addition of arabinoside C (1mM)
for 2 days and subsequent removing form the cultures
usingα-Thy1antibody-coupledmagneticbeads(Dynabeads,
Dynal, Denmark). The protocol resulted in about 99% pure
na¨ ıve SCs cultures.
Overexpression of FGF-2-isoforms was induced by trans-
fection of SCs using Metafectene (Biontex, Germany) [25],
transfectionrateapproximately20%,andplasmidconstructs
with FGF-218kD isoform [26] or FGF-221/23kD isoforms in
pCI-neo [20].
All SC populations transplanted in this study were
freshly prepared and transfected. As described earlier [15],
transfected SCs were positively selected for their coexpressed
resistance to Geneticin (G418) and successful transfection
was monitored in Western blot analysis with regard to
FGF-2 isoform overexpression in the diﬀerent cell groups
(Figure 2): nontransfected SCs (SCphysiol), SCs overex-
pressing either 18kD-FGF-2 (SC-FGF-218) or 21/23-kD-
FGF-2 (SC-FGF-221/23). Transfected cells were grown to
conﬂuence and withdrawn from fetal calf serum prior to
transplantation. SCs were detached from culture ﬂasks and
stored on ice. Directly prior to implantation of the silicon
nerve guides, SCs were resuspended in the collagen solution
(see above) and injected in the sterile silicone tubes used.
Transplanted SCs overexpressing FGF-2-18kD or FGF2-
21/23kD increase the amount of these proteins inside
a peripheral nerve gap after entubulation surgery. Using
the ELISA technique we previously found higher concen-
trations of free FGF-2 isoforms for at least one week
after entubulation. The amounts of free FGF-2 one week
after surgery were (1) nonmanipulated neonatal Schwann
cells (SC): 0.56ng/μL; (2) SC overexpressing the FGF-2-
18kD:0.90ng/μL;(3)SCoverexpressingtheFGF-2-21/23kD:
0.66ng/μL[ 20].
2.4. Identiﬁcation of SC Grafts. Identiﬁcation of SCs after
transplantation could be achieved by cell surface labeling
prior to grafting [27]. Exemplarily, prelabeling was per-
formed by the incubation of SCs with PKH26-GL cell
linker (Sigma, Germany). After sacriﬁce, tissue was ﬁxed
(4% paraformaldehyde), cryo-preserved (30% sucrose), and
cryo-embedded. Transplanted SCs were identiﬁed by their
red ﬂuorescence using a BX60 microscope (Leica, Germany)
in longitudinal cryo sections of regenerated peripheral nerve
tissue (Figure 4).
2.5. Manual Mechanical Stimulation of the Vibrissal Muscles.
As previously described, manual mechanical stimulation was
initiated one day after surgery [17]. To mimick natural
active vibrissal movements during whisking, groups 6–9
received daily gentle rhythmic forward stroking by hand,
while letting the whiskers retract backwards unassisted, of
the right vibrissae and whisker pad muscles (5min/day,
5days/week for 2 months; ﬁgure not shown, see [17]).
2.6. Analysis of Vibrissal Motor Performance. Animals were
videotaped for 3–5 minutes when undertaking active
exploratory sweeps [28]. We evaluated (i) protraction (for-
ward vibrissal movement); (ii) whisking frequency, (cycles
of protraction and retraction, that is, backward movement);
(iii) amplitude (diﬀerence between maximal retraction;
maximal protraction and (iv) angular velocity (degrees per
second). Measurements for all rats were performed by three
independent observers (S.K. Angelova, D. B¨ o s e l ,D .F e l d e r )
blinded to the treatment.
2.7. Estimation of Axonal Branching by Triple Retrograde
Labeling. Application of Fluorescencent Tracers. The protocol
followed our previously described method [21]. Brieﬂy,
one day after videotaping animals were anesthetized and
crystals of DiI (1,1 -dioctadecyl-3,3,3 ,3 -tetramethylindo-
carbocyanine perchlorate; Molecular Probes, The Nether-
lands), Fluoro-Gold (FG; Fluorochrome Inc., Denver, Colo,
USA) and Fast Blue (FB; EMS-Chemie GmbH, Groß-
Umstadt, Germany) instilled, respectively, into the zygo-
matic, buccal, and marginal mandibular branches of the
facial nerve (Figure 3). Ten days later, animals were ter-
minally anaesthetized and transcardially perfused (4%
formaldehyde in 0.1M phosphate buﬀer, pH 7.4). Brain-
stems were serially sectioned (vibratome, frontal, 50μm).
Fluorescence microscopy. Sections were observed
using an epiﬂuorescence microscope (Axioskop 50; ZeissJournal of Biomedicine and Biotechnology 5
Positive
control
Positive control
FGF-221/23 SC-FGF-221/23
SC-FGF-218
FGF-218 FGF-221/23 SCphysiol
SCphysiol
Figure 2: Western Blot analysis of Schwann cell populations prior to transplantation: nontransfected SCs, SCphysiol, show less amount of
FGF-2 isoforms (18kD, 21kD, and 23kD) as SCs genetically modiﬁed to overexpress FGF-2-18kD, SC-FGF-218, or FGF-2-21/23kD, SC-FGF-
221/23. As positive controls served cell lysates from FGF-2 isoform overexpressing PC12 cells.
Table 3: Quality of target muscle reinnervation. Reinnervation pattern of the levator labii superioris motor-end plates in intact rats, in rats
after transection of the right facial nery followed by:- entubulation with collagen only, with collagen plus naive SC’s, or with collagen plus
genetically modiﬁed SC’s. In group 6–9 entubulations were followed by manual mechanical stimulation (MS) of the vibrissal muscles. Motor
endplates were classiﬁed a monoinnervated, polyinnervated, or noninnervated according to the number of beta-tubulin-immunoreactive
axons that crossed th boundaries of the end-plate).
Group of animals Monoinnervated motor
end-plates (percent)
Polyinnervated
motor
end-plates
(percent)
Noninnervated
motor
end-plates
(percent)
Total number of
motor
end-plates
examined
1. Intact SD rats 100 ± 0.0 0.0 0.0 1633 ± 143
2. Collagen only 44 ± 8.0∗ 46± 10∗ 10 ± 3.0∗ 1521 ± 162
3. Collagen +neonatal, naive SC’s 42 ± 8.0∗ 49± 4.0∗ 9.0 ± 2.0∗ 1404 ± 108
4. Collagen + SC-FGF-218kD 49 ± 7.0∗ 45± 12∗ 6.0 ± 1.0∗ 1464 ± 159
5. Collagen + SC-FGF-221/23kD 48 ± 16∗ 47± 15∗ 5.0 ± 4.0∗ 1602 ± 258
6. Collagen only + MS 47 ± 9.0∗ 51± 10∗ 2.0 ± 1.0∗ 1362 ± 303
7 .C o l l a g e n+n e o n a t a l ,n a i v eS C ’ s+M S 40 ± 8.0∗ 48± 10∗ 12±3.0∗ 1512±102
8. Collagen + SC-FGF-218kD +M S 41 ± 3.0∗ 49± 11∗ 10±1.0∗ 1413±141
9. Collagen + SC-FGF-221/23kD +M S 51 ± 8.0∗ 42± 10∗ 7 ± 3.0∗ 1602 ± 150
∗Signiﬁcant diﬀerences of group mean values (ANOVA and post-hoc Tukey’s test, P<. 05 from intact rats.
Oberkochen, Germany) ﬁtted with a custom-made band
pass-ﬁlter set (AHF Analysentechnik, T¨ ubingen, Germany)
toeliminateﬂuorescencecross-talkbetweentracers.Separate
colorimagesofretrogradelylabeledfacialmotoneuronswere
generated (CCD Video Camera System: Optronics DEI-470,
Goleta, Calif, USA) and combined using image analysis
software Optimas 6.5. (Optimas Corporation, Bothell,
Wash, USA). All cells stained by DiIonly,F G only,F B only,a s
well as those double-stained (i.e., DiI+FG or DiI+FB) were
counted using an optical dissector technique [29]. The
counts therefore allowed us to quantify the degree (index) of
axonal branching (i.e., sum of the percentages given in the
third and fourth column in Table 2).
Double-labeled motoneuronal perikary with FG+FG (in
green colour) was not counted. This was a pity, because since
FG and FB were both simultaneously visualized with the
same UV epi-ﬂuorescence excitation ﬁlter (Zeiss, Filter set
01), such a measurement would be rather easy. However,
earlier own work has shown that the blue emission of FB
obscured the yellow emission of FG. In other words, the
number of FB+FG-labeled perikarya would be always lower
than its real value [30].
2.8. Analysis of Target Muscle Reinnervation. As described
previously, we quantiﬁed the ratio of monoinnervated
to poly-innervated motor endplates in the levator labii
superioris muscle [31] .C r y o p r o t e c t e dm u s c l et i s s u ew a s
cut on a cryostat (longitudinal; 30μm thick sections)
and sections immunostained (rabbit polyclonal antibody
against neuronal class III β-tubulin; Covance, Richmond,
Calif, USA, No. PRB-435P, 1 : 1000 and Cy3-conjugated
antirabbit IgG; 1 : 400; Sigma as a secondary antibody). The
boundaries of the motor end-plates were visualized using
acetylcholine receptor staining (Alexa Fluor 488-conjugated
alpha-bungarotoxin; Molecular Probes, 1 : 500).
2.9.StatisticalEvaluation. Datawereanalyzedusingone-way
ANOVA with post-hoc Tukey test and signiﬁcance level of
0.05 (Statistica 6.0 software; StatSoft, Tulsa, OK, USA).
3. Results
3.1.IdentiﬁcationofSCs. Examinationoftissueaftersacriﬁce
showed that transplanted neonatal SC integrated well into
regenerating peripheral nerve tissue (Figure 4).6 Journal of Biomedicine and Biotechnology
Intact
Buccal Zygomatic
Mandibular
(a)
100 µm
(b)
SC
(c)
100 µm
(d)
Figure 3: Myotopic organization of the facial nucleus and collateral axonal branching as estimated by the pattern of retrograde labeling. In
intact animals, simultaneous application of DiI (red), FG (yellow), and FB (blue) to the zygomatic, buccal and mandibular nerve branches,
respectively, labels distinct subnuclei with no overlap (a), (b). Two months after entubulation with collagen or collagen plus SC the myotopic
organization is lost irrespective whether the animals received MS (c), (d).
200 µm
Figure 4: Depicts exemplarily red-ﬂuorescent PKH26-GL cell
surface staining of transplanted SCs (red arrows, costained with
DAPI in blue) in a longitudinal cryostat section through the
regrown nerve in a silicone tube 3 weeks post-operation.
3.2. Manual Stimulation of Vibrissal Muscles Does Not
Promote Recovery of Whisking after Grafting Na¨ ıve SCs or
Those Overexpressing FGF-218kD or FGF-221/23kD. We ﬁrst
examined the eﬀects of MS on the return of whisking
function. As described by us and others, normal animals
exploretheenvironmentbycoordinatedsweepsofindividual
vibrissae (whisking) with a frequency of about 6Hz [28].
Vibrissal movements occur via muscle contractions which
produce active rostral protraction and, to a lesser extent,
active caudal retraction; that is, some of the backward
movement is passive. The amplitude of the movement
from maximum protraction to maximum retraction was
approximately 50◦ (Table 1, ﬁrst row).
Compared to normal animals, vibrissal motion was poor
in rats receiving entubulation alone (i.e., no manual stimu-
lation) of the facial nerve in collagen (group 2) or collagen
plus na¨ ıve SC or plus SC-FGF-218kD or SC-FGF-221/23kD
(groups 3–5) with the amplitude and angular velocity being
reduced by about 70% (Table 1). Furthermore, MS following
entubulation in collagen (group 6) or collagen + na¨ ıve and
FGF-overexpressing SC (groups 7–9) also failed to improve
whisking of the vibrissae (Table 1).
3.3. A High Degree of Collateral Axonal Branching Occurs
Regardless of Postoperative Treatment. As previously
described by us and others, in intact animals, motoneurons
with axons entering the zygomatic, buccal or marginal
mandibular ramus (Figure 3(a)) were myotopically
organized in the dorsal, lateral, and intermediate facial
subnuclei, respectively [16]. No double- or triple-labeled
motoneurons were observed because intact motoneuronsJournal of Biomedicine and Biotechnology 7
send only one unbranched axon into each of the facialis rami
(Figure 3(b)). Thus, for intact animals the index of axonal
branching in the facial nerve trunk, calculated by examining
the zygomatic motoneurons, was 0% (Table 2).
After facial nerve cut and entubulation with collagen or
collagen plus SCs but without MS (Figure 3(c)), myotopic
organization into speciﬁc subnuclei was no longer observed,
that is, all retrogradely labeled motoneurons were scattered
throughout the facial nucleus (Figure 3(d)). A similar lack
of myotopy was observed when manual stimulation was
combined with entubulation with collagen or collagen plus
na¨ ıveSCsorthoseoverexpressingFGF-218kD orFGF-221/23kD.
The lack of myotopy was presumably due to individual
transected axons sprouting to produce numerous collateral
branches [31] which grew into diﬀerent facial nerve rami,
persisted in the long-term and retrogradely transported the
three ﬂuorescent dyes to their parent motoneurons in the
facial nucleus.
We also commonly observed double and triple labeling
of motoneurons (Figure 3(d)). Multiple labeling of indi-
vidual motoneurons can be explained by injury-induced
collateral axonal branches projecting into diﬀerent facial
nerve rami (i.e., in this experiment, the ones that were
labeled, namely, the ramus zygomaticus, ramus buccalis
or ramus marginalis mandibulae). Such branches would
have retrogradely transported two or three ﬂuorescent dyes
simultaneouslytotheparentperikarya.Theﬁnalobservation
is that based on elevated motoneuron numbers in the facial
nucleus for all experimental animals, each of the individual
facialnerveramicontainedaxonsoraxonalbranchesofmore
motoneurons than in intact animals.
Retrograde tracing also revealed that transection and
entubulation of the facial nerve signiﬁcantly changed the
ﬁber composition of the diﬀerent rami (Table 2). In intact
rats (Group 1), the total number of single-labeled (i.e.,
DiI-only + FG-only + FB-only) cells in the facial nucleus
was about 2000 but increased to 4000–5000 following
entubulation with collagen, with neonatal SC and with
SCs overexpressing FGF-218kD or FGF-221/23kD isoforms
(last column in Table 1). A similar scenario was observed
following MS in groups 6–9 in which the total numbers of
single-labeled cells were signiﬁcantly increased compared to
those in intact rats (Table 1).
High numbers of single-labeled motoneurons presum-
ablyaroseasfollows.Axons inindividual ramidonot branch
in intact animals, and therefore retrograde labeling from
speciﬁc rami (zygomatic, buccal, and marginal mandibular)
yields consistent motoneuron numbers with little variation
(Table 2). The elevated numbers of motoneurons after
labeling the buccal(FG-only) and marginal mandibular (FB-
only), but not the zygomatic, branches (Table 2) indicate
that other axons must have sprouted and entered these rami.
The sources of these additional axons were presumably the
two other branches of the facial nerve (posterior auricular
and cervical). Thus, while not labeled in intact animals,
such axons must presumably have also sprouted into the
zygomatic, buccal, and marginal mandibular rami and,
therefore, have become labelled (Table 2).
Across all treatment groups, the index of axonal
branching (i.e., sum of the percentages of DiI+FG and
DiI+FB retrogradely labeled perikarya in the third and
fourth column of Table 2) was 46–67% and none of the
procedures signiﬁcantly inﬂuenced the projection patterns
(Figure 3(d)). Thus, to summarise, there was a complete
lack of myotopic organization, increased total numbers of
projecting motoneurons and a consistently elevated degree
of axonal branching regardless of whether the animals were
subjected to any of the paradigms or not.
3.4. Polyinnervation of the Motor Endplates Persists Regard-
less of Postoperative Treatment. Reinnervation of individual
skeletal target muscle ﬁbers revealed that in contrast to intact
animals, in which all motor endplates were monoinnervated,
nerve transection followed by treatments with collagen,
na¨ ıve SCs or those overexpressing FGF-218kD or FGF-221/23kD
resulted in 45–49% of the motor endplates being polyinner-
vated, that is, innervated by two or more axons (groups 2–5;
Figure 5; Table 3). Furthermore, manual stimulation did not
reduce the degree of polyinnervation (groups 6–9; 42–51%,
Table 3).
4. Discussion
Here we show that regardless of the post-operative treat-
ment following facial nerve injury, the index of collateral
branching at the lesion site remained high (46–67%),
the proportion of polyinnervated motor endplates in the
musculature rose from 0% to 42–51% and the amplitude of
vibrissal whisking remained low, ranging from 25% to 30%
of that in intact animals. Thus, although axonal sprouting
occurred, it appeared to be invariant and occurred to a
similar extent for each of the treatment groups and none
was functionally useful. Furthermore, in contrast to previous
ﬁndings [17], daily MS of whiskerpad muscles failed to
“harness” the regenerative sprouting to deliver improved
postoperative recovery of function.
Growth of lesioned peripheral axons is vigorously
supported by a large number of trophic factors expressed
locally (review in [32]). Within an earlier experimental set
we tested the hypothesis that neutralization of diﬀusable
neurotrophicfactorsatthelesionsiteinratscouldreducethe
collateral branching of transected axons and thus improve
quality of reinnervation [33]. We inserted both ends of
the transected facial nerve into a silicon tube containing
collagen gel with neutralizing concentrations of antibodies
to several growth factors including FGF-2. Two months later,
retrograde labeling was used to estimate the proportion
of motoneurons with branched axons projecting into the
three major branches of the facial nerve. Neutralizing
concentration of anti-FGF-2 signiﬁcantly reduced the
index of collateral axonal branching to 22% [33]. Thus,
by manipulating the local environment using neutralizing
antibody to FGF2, we achieved a strong reduction in
collateral axonal branching from the proximal stump and
a signiﬁcant improvement of the reinnervation quality in
several groups of rats. In the same animals, however, the8 Journal of Biomedicine and Biotechnology
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Figure 5: (a) Schematic drawing of the extrinsic vibrissae muscles. α-δ: the four caudal hair follicles, the muscles slings of which “straddle”
the ﬁve vibrissae rows (A)–(E); T–m. transversus nasi; L–m. levator labii superioris; N–m. nasalis; M–m. maxilolabialis; O–orbit; S–septum
intermusculare. (b) and (c) are the superimposed stacks of confocal images of end-plates in LLS muscles of intact and surgically treated
rats visualized by staining of the motor end-plates with Alexa Fluor 488 α-bungarotoxin (green ﬂuorescence) and immunostaining of
the intramuscular axons for neuronal class III β-tubulin (Cy3 red ﬂuorescence). (b) and (c) show examples of a polyinnervated and
a monoinnervated end-plate, respectively. Three axonal branches (arrows in (b)) reach the boundaries of the polyinnervated end-plate
delineated by the alpha-bungarotoxin staining. In contrast, the monoinnervated end-plate is reached by a single axon (empty arrow in (c))
withseveralpreterminalrami.Inbothexamples,thewholeend-platesarewithinthestackofconfocalimages.Scalebarshownin(c)indicates
125μm( a d o p t e df r o m[ 31]).
function of the reinnervated vibrissae muscles remained
as poor as in nontreated injured animals. As a potential
reason for the ineﬀectiveness of the treatment we identiﬁed
the well-known posttransectional polyneuronal innervation
of the motor endplates, a phenomenon which was not
directly manipulated in our experiments. These results
raise questions of fundamental importance with regard to
the mechanisms limiting functional recovery and to the
perspectives for identifying new eﬃcient treatment strategies
[31].
So far we have no evidence that the observed pattern
of reinnervation and recovery of vibrissae whisking after
treatment with collagen, na¨ ıve SCs, or those overexpressing
FGF-218kD or FGF-221/23kD represent an endpoint, and not
just a delayed recovery. This is why we cannot exclude
that an improvement might take palce in these animals.
However, based on several long term clinical data [34]
and own observations [16, Chapter 3.1.5.] we anticipate
exactly the opposite. The persisting axonal misguidance
and poly-innervation of muscles (in contrast to the events
during embryonic development, there occurs no retrieval of
excessive axonal terminals from the NMJ in adults) cause
a wasting palsy (paresis and atrophy of the muscles) and
progressive functional deterioration. Anyway, to clear this
issue deﬁnitely, new experiments with longer postoperative
survival periods have to be performed.Journal of Biomedicine and Biotechnology 9
Within the CNS, transplantation of supportive cells,
such as Schwann cells, signiﬁcantly increases the extent of
regeneration within the bands of B¨ ungner—long chains
Schwann cells of cells, which bridge the interfragmentary
gapandformguidingchannelsfortheregeneratingbranches
on their way to the target(s) [2, 35, 36]. Schwann cell
transplantation is used within the PNS to bridge larger nerve
gaps that axons lacking physical and trophic support are not
able to cross [20]. Similar to autologous peripheral nerve
grafts, transplanted SCs in synthetic nerve bridges provide
regrowing peripheral axons with supportive environmental
conditions to overcome large nerve defects [37]. A further
advantage is that synthetic bridges avoid the problem of
removing nerve tissue for transplantation, which in turn
would induce its own defect. In particular, SCs have been
considered to be useful because of the large range of
neurotrophic factors that they naturally secrete [17, 38].
Synthetic nerve bridges can be constructed in a number of
ways [39]. The eﬃcacy of bridges containing neurotrophic
factors alone is limited by short half-life. Schwann cells,
however, could in addition to secreting their own range of
growth factors be genetically engineered exvivo to induce
long-term release of selected neurotrophic factors in a site-
directed manner [40].
Indeed, we have previously demonstrated that trans-
plantation of genetically modiﬁed SCs overexpressing FGF-2
into a large gap (15mm) in the rat sciatic nerve supported
functional recovery [20]. However, the type of recovery was
depended on the FGF-2 isoform. Whereas sensory recovery
wasacceleratedbyFGF-221/23kD,motorrecoveryseemedonly
to be inﬂuenced by FGF-218kD [11]. Additionally, it has
recently been demonstrated that FGF-2 deﬁcient mice show
a faster sensory recovery after sciatic nerve crush injury [41].
However, synergistic beneﬁcial eﬀects on promoting axonal
regrowth could be demonstrated for FGF-221/23kD, and not
FGF-218kD, gene therapy after sciatic nerve entubulation
surgery followed by motor-enriched rehabilitation, such as
voluntary wheel running [20]. Today there is no clear evi-
dence if motor axonal regeneration and functional recovery
ofamixedperipheralnervecouldbesupportedbyanyFGF-2
isoform alone.
In contrast, we have shown here, for the purely motor
facial nerve, that neither FGF-2 isoform, delivered via
an ex vivo gene therapy approach, increased the amount
of regeneration, as measured by the extent of sprouting,
nor enhanced functional recovery. Thus for both FGF-2
isoforms, the index of collateral axonal branching, that is,
sum of the percentages of DiI+FG (third column, Table 2)
plus DiI+FB (fourth column, Table 2) labeled neurons was
48% and 50%, respectively, and did not diﬀer signiﬁcantly
from collagen alone (54%) or na¨ ıve SCs (46%). The present
data thus suggest that although FGF-2 supports bridging
of the 5mm gap, this growth factor does not improve the
accuracy of regrowth of facial nerve axons over and above
that induced by collagen alone or na¨ ıve SCs.
Interestingly, the extent of collateral branching at the
lesion site in the current study may be somewhat less than
that induced by facial nerve transection and end-to-end re-
anastomosis (67% in [17], that is, without the ∼5mmgap
inherent during the silicone tube grafting procedure. This
indicates that the extent of collateral axonal branching at
the lesion site is somehow limited when the gap is large.
One possible reason could be found in the lack of a suture-
caused tight apposition between the regrowing neurites and
the approximated B¨ ungner’s bands of the distal fragment
undergoing Walerian degeneration.
Whereas it is evident that neither FGF-2 isoform confers
an advantage for bridging large defects in a pure motor
nerve like the facial nerve, FGF-221/23kD is clearly advanta-
geous within the mixed sciatic nerve: functional recovery
is improved to diﬀering degrees by the diﬀerent FGF-2
isoforms [20]. Furthermore, synergistic beneﬁcial eﬀects of
FGF-221/23kD gene therapy with regard to promoted axonal
growth was demonstrated for sciatic nerve entubulation
surgery followed by motor-enriched rehabilitation, such as
voluntary wheel running [18]. The reasons for the diﬀerence
in outcomes for the sciatic and facial nerve are unknown
but could include diﬀerences in the types of readouts and
assessments naturally associated with two such function-
ally diﬀerent nerves. In addition, depending on diﬀerent
stimuli applied, diﬀerences in target tissue signaling after
reconstructive surgery could have accounted for the diﬀerent
outcome in the discussed models: denervated muscles have
been shown to produce short-range diﬀusible sprouting
stimuli [42, 43]. Various growth factors have been identiﬁed
as possible candidates for this role [44]; described in what
follows). Their amount is inversely proportional on muscle
activity [45, 46]. A future set of experiments would be
needed to determine if ex vivo gene therapy with other
single or combined growth factors could beneﬁcially aﬀect
the outcome of facial nerve entubulation repair.
It is puzzling why a gap of only 5mm, which is after
all bridged successfully and located far from the target,
would hamper the eﬀects of manual stimulation of the
vibrissal muscles. What is the reason for the lack of reduced
polyinnervation of the motor end-plates? We do not know
that so far, but will try to answer this question using the
time course of target reinnervation. Let us assume that
mechanicalstimulation“simulates”suﬃcientmuscleactivity
and normal (i.e., nonincreased) local production of growth
factors only for a limited period of time, immediately after
the nerve lesion. This would allow the regrowing axons
to reach their motor targets slowly, accurately and with
less intramuscular terminal sprouting. After a 5mm nerve
gap, this time schedule cannot be followed anymore: the
regrowing axons need more time to bridge the gap. The
synchronously increased production of trophic factors urges
them to grow rapidly, with more intramuscular sprouts.
Thus it seems that though relative short, the gap of 5mm
is a serious hurdle for the eﬀects of manual mechanical
stimulation [47].
In summary, we show that although a gap of 5mm in
the facial nerve lesion paradigm can be successfully bridged
by entubulation, in terms of axonal sprouting, regeneration
across the gap is the same regardless of whether SCs are
present and also regardless of whether they overexpress FGF-
218kD/FGF-221/23kD. Comparison with end-to-end suturing
as a repair technique shows that the amount of sprouting10 Journal of Biomedicine and Biotechnology
might be reduced, the larger the gap, possibly due to the
lack of support and increased guidance errors. Furthermore,
manual stimulation, which is able to restore normal function
if the gap is small, fails to do so for any of the treatments
involvingentubulationinwhichthegapislong.Weconclude
thatalthough entubulation of a transected peripheral (facial)
nerveinsuspensionofSchwanncellswhcihoverexpressFGF-
218kD/FGF-221/23kD supports the axon regeneration through a
large (5mm) gap, the procedure induces excessive collateral
branchingatthelesionsiteandmassiveterminalsproutingin
themimicmuscles.Furthermore,underthesecircumstances,
the therapeutic procedure of manual stimulation of dener-
v a t e dm u s c l e sh a dn ob e n e ﬁ c i a le ﬀect.
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